Apollo Endosurgery Announces FDA Approval of Revised Labeling for the ORBERA® Intragastric Balloon System Medical Device Investing
TESARO Announces Collaboration to Evaluate ZEJULA in Combination With Anti-PD-L1 Cancer Immunotherapy and MEK Inhibitor in Platinum-Sensitive Ovarian Cancer Pharmaceutical Investing
Summit Therapeutics Reports Financial Results for the First Quarter Ended 30 April 2018 and Operational Progress Pharmaceutical Investing
Protalix BioTherapeutics Announces Additional Positive Results from Final Analysis of the Phase II Clinical Trial of OPRX-106 for the Treatment of Ulcerative Colitis Biotech Investing
Axsome Therapeutics Initiates Phase 2 Trial of AXS-05 in Major Depressive Disorder Pharmaceutical Investing
Isodiol International Inc. Completes Acquisition of Farmtiva Inc. for 51% Ownership and Completes First Planting of Farm Bill Compliant Hemp in California Cannabis Investing News
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
